BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Huang R, Li M, Zhu Z, Chen Z, Cui L, Luo H, Luo L. Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor. Cancer Cell Int 2020;20:561. [PMID: 33292235 DOI: 10.1186/s12935-020-01658-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Carlisi D, Lauricella M, D'Anneo A, De Blasio A, Celesia A, Pratelli G, Notaro A, Calvaruso G, Giuliano M, Emanuele S. Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties. Biomedicines 2022;10:514. [PMID: 35203723 DOI: 10.3390/biomedicines10020514] [Reference Citation Analysis]
3 Zhuang J, Chen Z, Chen Z, Chen J, Liu M, Xu X, Liu Y, Yang S, Hu Z, He F. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma. Respir Res 2022;23:123. [PMID: 35562727 DOI: 10.1186/s12931-022-02043-4] [Reference Citation Analysis]